1. Adams JD, Flora KP, Goldspiel BR, Wilson JW, Arbuck SG and Finley R (1993). Taxol: a history of pharmaceutical development and current pharmaceutical concerns. Monograph Natl. Cancer Inst. 15: 141–147
2. Alder JD, Jarvis KP, Marsh KC, Klein LL and Clement JJ (1996). Preclinical in vivo efficacy of two 9-dihydrotaxane analogues against human and murine tumours. Brit. J. Cancer 73: 560–564
3. Arbuck SG and Blaylock BA (1995). Taxol: clinical results and current issues in development. In: Suffness, M (eds) Taxol – Science and Applications, pp 379–415. CRC Press, Boca Raton, FL, USA
4. Baloglu E and Kingston DGI (1999). The taxane diterpenoids. J. Nat. Prod. 62: 1448–1472
5. Brown DT (2003). Preclinical and clinical studies of the taxanes. In: Itokawa, H and Lee, K-H (eds) Taxus – The Genus Taxus, pp 387–435. Taylor & Francis, London, UK